An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Clinical trial NCT00332917 · COMPLETED

Trial details

NCT number: NCT00332917
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Stage Parkinson's Disease

Start date: 2007-02-01
Primary completion: 2008-07-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.